| Breakdown | TTM | Oct 2025 | Oct 2024 | Oct 2023 | Oct 2022 | Oct 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 56.23B | 55.30B | 53.56B | 53.72B | 62.91B | 63.46B |
| Gross Profit | 11.33B | 11.05B | 11.82B | 11.51B | 12.26B | 13.41B |
| EBITDA | 4.07B | 4.09B | 4.72B | 4.47B | 5.46B | 8.61B |
| Net Income | 2.51B | 2.53B | 2.77B | 3.26B | 3.13B | 6.54B |
Balance Sheet | ||||||
| Total Assets | 41.53B | 41.77B | 39.91B | 37.00B | 38.49B | 38.60B |
| Cash, Cash Equivalents and Short-Term Investments | 3.15B | 3.69B | 3.24B | 3.11B | 3.15B | 4.30B |
| Total Debt | 9.70B | 10.88B | 10.90B | 10.74B | 12.29B | 8.78B |
| Total Liabilities | 38.13B | 42.12B | 41.23B | 38.07B | 41.52B | 40.25B |
| Stockholders Equity | 3.41B | -346.00M | -1.32B | -1.07B | -3.02B | -1.64B |
Cash Flow | ||||||
| Free Cash Flow | 2.88B | 2.80B | 3.16B | 2.96B | 3.67B | 5.83B |
| Operating Cash Flow | 3.71B | 3.70B | 3.75B | 3.57B | 4.46B | 6.41B |
| Investing Cash Flow | -1.15B | -1.18B | -646.00M | -590.00M | -3.55B | -1.01B |
| Financing Cash Flow | -2.30B | -2.06B | -3.08B | -2.89B | -2.07B | -5.96B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | $94.83B | 28.08 | 41.27% | 0.18% | -16.35% | 316.56% | |
70 Outperform | $88.94B | 46.12 | ― | 1.02% | 31.56% | 106.00% | |
64 Neutral | $19.54B | 16.57 | 112.59% | 1.89% | 2.64% | 4.12% | |
62 Neutral | $98.13B | 17.06 | ― | 1.45% | 10.81% | 31.67% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
58 Neutral | $19.40B | 24.05 | 13.19% | ― | 12.22% | -48.34% | |
57 Neutral | $17.37B | 7.17 | ― | 5.09% | 4.09% | -5.77% |
On February 3, 2026, HP Inc. announced a leadership transition in which long-time executive Enrique Lores stepped down as president, chief executive officer and board member at the end of February 2, 2026, to pursue another professional opportunity, and board member Bruce Broussard was appointed interim CEO effective February 3, 2026. Broussard, a veteran public-company leader with extensive experience at Humana and US Oncology/McKesson, will retain his board seat but relinquish key committee roles, and will receive a substantial interim CEO compensation package including monthly cash pay and a $7 million restricted stock grant that vests in 2027; meanwhile, HP’s board has formed a CEO search committee and hired an executive search firm, while the company reaffirmed its earnings and cash-flow outlook for the first quarter and full fiscal year 2026, signaling an intent to maintain strategic continuity and operational stability for investors and other stakeholders during the management transition.
The most recent analyst rating on (HPQ) stock is a Hold with a $20.50 price target. To see the full list of analyst forecasts on HP stock, see the HPQ Stock Forecast page.